{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-301052","form_type":"8-K","ticker":"CUE","cik":"0001645460","company_name":"Cue Biopharma, Inc.","filed_at":"2026-07-10T21:29:46+00:00","discovered_at":"2026-07-10T21:32:00.288968+00:00","generated_at":"2026-07-10T21:32:08.884121+00:00","sec_items":["1.01","3.02","5.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cue Biopharma raises $50M in private placement led by Cormorant and Columbia Threadneedle","bullets":["Gross proceeds of $50M from sale of 1,418,071 shares at $33.21/share and pre-funded warrants for 87,500 shares at $33.209.","Private placement led by Cormorant Asset Management and Columbia Threadneedle Investments; expected to close July 13, 2026.","Net proceeds to fund clinical development and general corporate purposes; CEO cites upcoming Phase 2 CSU data from Ascendant Health expected by Q3 2026.","Board granted 1,064,492 RSUs to employees and executives, including 655,074 RSUs to CEO Shao-Lee Lin, with time and performance-based vesting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-301052","json":"https://secwatch.observer/filing/0001193125-26-301052.json","markdown":"https://secwatch.observer/filing/0001193125-26-301052.md","text":"https://secwatch.observer/filing/0001193125-26-301052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526301052/0001193125-26-301052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645460/000119312526301052/d123955d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-10T21:32:08.884121+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}